2012 Process Development Symposium

Why PDS 2012?

The Process Development Symposium is offered as a means for development professionals to discuss experiences in the hope that, collectively, we can refine our predictive abilities and repeat good habits while rejecting bad ones.

Topics addressed at the symposium are germane to all industries that are served by chemical engineers and chemists. Experts from the chemical, pharmaceutical, food, electronics, oil and gas and specialty chemicals’ businesses will share ideas and proven methodologies for early recognition of troublesome technical and non-technical issues and their resolution.

Highlights

Opening Keynote: Addressing Pharmaceutical Process Development Challenges

Mauricio Futran, Rutgers University, addresses process development challenges affecting the pharmaceutical industry, which is undergoing major changes. More than $100 Billion in patent protected products are facing generic competition this decade.

Session II: Inherently Safer Processes

Session Chair Kathy Kas, The Dow Chemical Co. Schedule Presentation Speaker Introduction to Inherently Safer Design Dennis Hendershot The Design of Safe, Efficient and Green Processes for API’s Throughout Product Lifecycle John Dillon Introduction to Inherently Safer Design Dennis Hendershot, CCPS...

Who Should Attend?

Those who work in areas of product and process development are expected to learn new and useful approaches for meeting the challenges of project success. Technical issues such as scale-up problems and non-technical issues such as effective communication with managers and other functions will be addressed. This year's symposium is dedicated to providing a forum for discussion of major technical issues such as identifying innovative ideas and addressing scale-up problems, information, and know-how needed to plan for success from the beginning.

Featured Speakers

Mauricio Futran

Mauricio Futran is Professor and Chair of Chemical and Biochemical Engineering at Rutgers University. He came to this position after 28 years of pharmaceutical product and process development work at Merck and Co. and Bristol-Myers Squibb, where he was Vice President of Process R&D. His areas of expertise include all aspects of process development, technology transfer, validation, regulatory compliance, new product registration worldwide, external manufacturing and partnership development.

More Conference Highlights

Proceedings

Proceedings of the 2012 Process Development Symposium are now available:

Browse Online Proceedings

Search form